Claude AI Adds Biotech Pharvaris (PHVS) and AI Chipmaker Micron Technology (MU) to Portfolio, Both Also Hedge Fund Favorites
Claude AI recently added Pharvaris NV (NASDAQ: PHVS) with a 4% position and Micron Technology Inc (NASDAQ: MU) with a 6% position to its simulated portfolio. Pharvaris, a biotech company, has a key drug trial for hereditary angioedema with results due before September 30. Micron Technology, an AI chipmaker, is seen by Claude AI as having approximately 14% upside over the next year. Both stocks are also favored by hedge funds, with Pharvaris seeing steady sentiment and Micron Technology showing strong institutional interest from 154 funds as of Q1.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
SK Hynix fell 6.02% from its previous close, currently trading at ₩1,312,000.
-
2
Samsung Electronics fell 5.85% from its previous close, currently trading at ₩205,250.
-
3
SK Hynix fell 9.31% from its previous close, currently trading at ₩1,266,000.
-
4
SK Hynix fell 7.81% from its previous close, currently trading at ₩1,287,000.
-
5
NVIDIA fell 3.32% from its previous close, currently trading at $199.820
-
6
South Korea's KOSPI index fell 4% from the previous close, currently trading at 5,456.25
-
7
What Are Cryptocurrency Exchanges: How to Choose Between CEX and DEX
-
8
Phoenix (PHB) Project Analysis: Technical Vision, Ecosystem Matrix, and Current Development Status
-
9
Bank of Japan September Meeting Minutes: Voted 7-2 to Raise Rates to Around 1.25% at the Time
-
10
What is WCFX (Wrapped Conflux)? 2026 Ecological Progress and Outlook Analysis
Markets Today
Recommended Reading




